Literature DB >> 19062203

Changes in feeding and locomotion induced by amphetamine analogs in rats.

Paul J Wellman1, Kristina W Davis, P Shane Clifford, Richard B Rothman, Bruce E Blough.   

Abstract

Studies of the biobehavioral actions of psychostimulants commonly focus on locomotion and less commonly on feeding, and only rarely are these measures considered in conjunction within the same animal. The present study compared the impact of (+)-amphetamine and three amphetamine analogs, PAL-287, PAL-313, and PAL-353, on eating and locomotion assessed concurrently using an automated activity/feeding chamber during a daily 45 min session. Each analog is a potent releaser of norepinephrine and of dopamine, but exerts differential serotonin-releasing activity (PAL-287>PAL-313>amphetamine>PAL-353). Rats were tested with each of five doses of drug (0, 2, 4, 8, or 16 micromol/kg, i.p.), given in equimolar concentrations and in random dose order. PAL-353, an analog with minimal serotonin-releasing capacity, markedly stimulated forward locomotion at 2, 4, 8 and 16 micromol/kg, as did amphetamine, whereas PAL-287 and PAL-313 did not. In contrast to the locomotor findings, all four amphetamine-like drugs exerted similar effects on the suppression of food intake. These results suggest that the capacity of an amphetamine analog (i.e. amphetamine and PAL-353) to stimulate serotonin release can diminish its psychostimulant action on locomotion, but does not reliably augment drug-induced hypophagia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19062203      PMCID: PMC2758604          DOI: 10.1016/j.drugalcdep.2008.10.005

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  43 in total

Review 1.  Conditioned place preference: what does it add to our preclinical understanding of drug reward?

Authors:  M T Bardo; R A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2000-12       Impact factor: 4.530

2.  Effects of selective dopamine D1 or D2 receptor blockade within nucleus accumbens subregions on ingestive behavior and associated motor activity.

Authors:  Brian A Baldo; Ken Sadeghian; Ana Maria Basso; Ann E Kelley
Journal:  Behav Brain Res       Date:  2002-12-02       Impact factor: 3.332

3.  Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression.

Authors:  D M Donovan; L L Miner; M P Perry; R S Revay; L G Sharpe; S Przedborski; V Kostic; R M Philpot; C L Kirstein; R B Rothman; C W Schindler; G R Uhl
Journal:  Brain Res Mol Brain Res       Date:  1999-11-10

4.  Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.

Authors:  Candice Drouin; Gérard Blanc; Anne-Sophie Villégier; Jacques Glowinski; Jean-Pol Tassin
Journal:  Synapse       Date:  2002-01       Impact factor: 2.562

5.  Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates.

Authors:  Candice Drouin; Laurent Darracq; Fabrice Trovero; Gérard Blanc; Jacques Glowinski; Susanna Cotecchia; Jean-Pol Tassin
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

6.  Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.

Authors:  R B Rothman; M H Baumann; C M Dersch; D V Romero; K C Rice; F I Carroll; J S Partilla
Journal:  Synapse       Date:  2001-01       Impact factor: 2.562

7.  Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys.

Authors:  S S Negus; N K Mello; B E Blough; M H Baumann; R B Rothman
Journal:  J Pharmacol Exp Ther       Date:  2006-10-27       Impact factor: 4.030

8.  Appetite suppressants as agonist substitution therapies for stimulant dependence.

Authors:  Richard B Rothman; Bruce E Blough; Michael H Baumann
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

9.  Cocaine-induced hypophagia and hyperlocomotion in rats are attenuated by prazosin.

Authors:  Paul Wellman; Dao Ho; Antonio Cepeda-Benito; Larry Bellinger; Jack Nation
Journal:  Eur J Pharmacol       Date:  2002-11-29       Impact factor: 4.432

Review 10.  Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms.

Authors:  Kenneth D Carr
Journal:  Physiol Behav       Date:  2002-07
View more
  9 in total

1.  In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat.

Authors:  Michael H Baumann; Robert D Clark; William L Woolverton; Sunmee Wee; Bruce E Blough; Richard B Rothman
Journal:  J Pharmacol Exp Ther       Date:  2011-01-12       Impact factor: 4.030

2.  Perinatal lead exposure alters locomotion induced by amphetamine analogs in rats.

Authors:  P Shane Clifford; Nigel Hart; Richard B Rothman; Bruce E Blough; Gerald R Bratton; Paul J Wellman
Journal:  Life Sci       Date:  2011-01-21       Impact factor: 5.037

3.  The effects of amphetamine injections on feeding behavior and the brain expression of orexin, CART, tyrosine hydroxylase (TH) and thyrotropin releasing hormone (TRH) in goldfish (Carassius auratus).

Authors:  Hélène Volkoff
Journal:  Fish Physiol Biochem       Date:  2012-12-11       Impact factor: 2.794

4.  Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey.

Authors:  Heather L Kimmel; Daniel F Manvich; Bruce E Blough; S Stevens Negus; Leonard L Howell
Journal:  Pharmacol Biochem Behav       Date:  2009-09-17       Impact factor: 3.533

5.  Prenatal lead exposure enhances methamphetamine sensitization in rats.

Authors:  P Shane Clifford; Nigel Hart; Jeff Thompson; Sam Buckman; Paul J Wellman; Gerald R Bratton; Jack R Nation
Journal:  Pharmacol Biochem Behav       Date:  2009-05-09       Impact factor: 3.533

6.  Light/dark phase-dependent spontaneous activity is maintained in dopamine-deficient mice.

Authors:  Masayo Fujita; Yoko Hagino; Taishi Takeda; Shinya Kasai; Miho Tanaka; Yukio Takamatsu; Kazuto Kobayashi; Kazutaka Ikeda
Journal:  Mol Brain       Date:  2017-10-16       Impact factor: 4.041

7.  Balancing risk and reward: a rat model of risky decision making.

Authors:  Nicholas W Simon; Ryan J Gilbert; Jeffrey D Mayse; Jennifer L Bizon; Barry Setlow
Journal:  Neuropsychopharmacology       Date:  2009-05-13       Impact factor: 7.853

Review 8.  Ghrelin and ghrelin receptor modulation of psychostimulant action.

Authors:  Paul J Wellman; P Shane Clifford; Juan A Rodriguez
Journal:  Front Neurosci       Date:  2013-09-25       Impact factor: 4.677

9.  Amphetamine reduces reward encoding and stabilizes neural dynamics in rat anterior cingulate cortex.

Authors:  Saeedeh Hashemnia; David R Euston; Aaron J Gruber
Journal:  Elife       Date:  2020-08-19       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.